The EMEA has issued a positive opinion recommending approval for Neupro (rotigotine) for moderate-to-severe idiopathic Restless Legs Syndrome (RLS) in adults. Neupro is already launched for Parkins… more →
GPCR Newscrimsoncanary wrote 4 months ago: The EMEA has issued a positive opinion recommending approval for Neupro (rotigotine) for moderate- … more →